Cell cycle checkpoint kinase (CHK)1 inhibition induces immune modulation in recurrent BRCA wild-type high-grade serous ovarian cancer (HGSOC) patients

被引：0
|
作者：
Lampert, Erika J. [1 ]
Lee, Min-Jung [1 ]
Trepel, Jane B. [1 ]
Yuno, Akira [1 ]
Cimino-Mathews, Ashley [2 ]
Lee, Joo-Sang [1 ]
Ruppin, Eytan [1 ]
Nair, Jayakumar [1 ]
Ekwede, Irene [1 ]
Lee, Jung-Min [1 ]
机构：
[1] NCI, Ctr Canc Res, Bethesda, MD 20892 USA
[2] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-5000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5000
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with BRCA1/2 Mutation: A Korean Multicenter Study
    Paik, E. Sun
    Lee, Yong Jae
    Lee, Jung-Yun
    Shin, Wonkyo
    Park, Sang-Yoon
    Kim, Se Ik
    Kim, Jae-Weon
    Choi, Chel Hun
    Kim, Byoung-Gie
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (11)
  • [42] BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma
    McAlpine, Jessica N.
    Porter, Henry
    Koebel, Martin
    Nelson, Brad H.
    Prentice, Leah M.
    Kalloger, Steve E.
    Senz, Janine
    Milne, Katy
    Ding, Jiarui
    Shah, Sohrab P.
    Huntsman, David G.
    Gilks, C. Blake
    MODERN PATHOLOGY, 2012, 25 (05) : 740 - 750
  • [43] Real-world experience of olaparib maintenance in high grade serous recurrent ovarian cancer patients with BRCA 1/2 mutation
    Paik, E. S.
    Kim, J.
    Kim, T-J.
    Choi, C. H.
    Lee, J-W.
    Bae, D-S.
    Kim, B-G.
    ANNALS OF ONCOLOGY, 2018, 29 : 84 - 84
  • [44] Anti-tumor activity and molecular correlates of the Chk1 inhibitor prexasertib (LY2606368) as a single agent in models of human high-grade serous ovarian cancer (HGSOC)
    Wu, W.
    Dempsey, J.
    Abel, A.
    Donoho, G.
    Stephens, J.
    Iversen, P.
    Mc Nulty, A.
    Martinez, R.
    Mcneely, S.
    Szpurka, H.
    Schade, A.
    Reinhard, C.
    Stancato, L.
    Lin, A.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E4 - E4
  • [45] STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer
    Abdi Ghaffari
    Nichole Peterson
    Kasra Khalaj
    Natasha Vitkin
    Andrew Robinson
    Julie-Ann Francis
    Madhuri Koti
    British Journal of Cancer, 2018, 119 : 440 - 449
  • [46] BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients - A study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD)
    Ruscito, I.
    Dimitrova, D.
    Vasconcelos, I.
    Gellhaus, K.
    Schwachula, T.
    Bellati, F.
    Zeillinger, R.
    Benedetti-Panici, P.
    Vergote, I.
    Mahner, S.
    Cacsire-Tong, D.
    Concin, N.
    Darb-Esfahani, S.
    Lambrechts, S.
    Sehouli, J.
    Olek, S.
    Braicu, E. I.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (12) : 2090 - 2098
  • [47] STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer
    Ghaffari, Abdi
    Peterson, Nichole
    Khalaj, Kasra
    Vitkin, Natasha
    Robinson, Andrew
    Francis, Julie-Ann
    Koti, Madhuri
    BRITISH JOURNAL OF CANCER, 2018, 119 (04) : 440 - 449
  • [48] Reversion of BRCA1/2 Germline Mutations Detected in Circulating Tumor DNA From Patients With High-Grade Serous Ovarian Cancer
    Christie, Elizabeth L.
    Fereday, Sian
    Doig, Ken
    Pattnaik, Swetansu
    Dawson, Sarah-Jane
    Bowtell, David D. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (12) : 1274 - 1280
  • [49] Oncologists’ perspectives of telephone genetic counseling to facilitate germline BRCA1/2 testing for their patients with high-grade serous ovarian cancer
    Pierre Hemming
    Rajneesh Kaur
    Bettina Meiser
    Joanne McKinley
    Mary-Anne Young
    Paul A. James
    Laura E. Forrest
    Journal of Community Genetics, 2021, 12 : 449 - 457
  • [50] Oncologists' perspectives of telephone genetic counseling to facilitate germline BRCA1/2 testing for their patients with high-grade serous ovarian cancer
    Hemming, Pierre
    Kaur, Rajneesh
    Meiser, Bettina
    McKinley, Joanne
    Young, Mary-Anne
    James, Paul A.
    Forrest, Laura E.
    JOURNAL OF COMMUNITY GENETICS, 2021, 12 (03) : 449 - 457
12345